HeartBeam to Report Q1 2026 Results and Update on Commercial Launch and AI Programs

HeartBeam Inc. (NASDAQ: BEAT), a medical technology company focused on cardiac care innovation, announced it will host a conference call on May 13, 2026, at 4:30 p.m. Eastern time to discuss its first-quarter results for the period ended March 31, 2026, and provide updates on key growth initiatives. These include the limited commercial launch for arrhythmia assessment, extended-wear patch development, heart attack detection, and AI programs.

The company’s 3D ECG technology, which received FDA clearance for arrhythmia assessment in December 2024 and for 12-lead ECG synthesis software in December 2025, is designed to enable cable-free, portable cardiac monitoring. The platform collects ECG signals in three non-coplanar directions and synthesizes them into a 12-lead ECG, allowing physicians to identify cardiac health trends and acute conditions outside of medical facilities. HeartBeam holds over 20 issued patents related to its technology.

The upcoming earnings call will provide investors and stakeholders with insights into the company’s financial performance and strategic direction. The limited commercial launch for arrhythmia assessment represents a critical step toward broader market adoption, while the extended-wear patch and AI programs aim to expand the platform’s capabilities for continuous monitoring and early detection of cardiac events.

HeartBeam’s technology has the potential to redefine cardiac health management by delivering actionable intelligence directly to patients and healthcare providers. The company’s focus on heart attack detection and AI-driven analytics underscores its commitment to addressing critical gaps in cardiac care. For more details on the cleared indications for use, visit HeartBeam Indications.

Investors can access the full press release and additional information through the company’s newsroom at HeartBeam Newsroom. The conference call will be webcast and available for replay on the company’s website.